CSHL Press begins 2021 with new and expanded transformational publishing agreements

17 May 2021 – Cold Spring Harbor Laboratory Press, a nonprofit publisher of leading research journals in molecular biology, genetics, and related fields, is pleased to announce its first set of transformational publishing agreements, effective from January 1, 2021. “A sustainable path to open publication of biomedical research is a long-sought objective at Cold Spring…

Uzuner receives funding for economic impact analysis

Ozlem Uzuner, Associate Professor and Interim Chair, Information Sciences and Technology, received $222,469 from the U.S. Department of Health and Human Services for a large-scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports. Uzuner and her team will contribute to two aims of this project: (1) Extraction of incidentaloma frame…

Civil commitment for substance use disorder treatment — what do addiction medicine specialists think?

May 17, 2021 – Amid the rising toll of opioid overdoses and deaths in the U.S., several states are considering laws enabling civil commitment for involuntary treatment of patients with substance use disorders (SUDs). Most addiction medicine physicians support civil commitment for SUD treatment – but others strongly oppose this approach, reports a survey study…

Damage-Free Blow Dry Tips

It seems that there is nothing wrong with blow-drying. But it turns out that improper blow-drying can be very harmful to your gorgeous hair. So how can you prevent this harmful impact? We all know that regular blow-drying can dehydrate hair and break its structure. Before using the hot air, it is worth familiarizing yourself…

Novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis

The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai. The fully human monoclonal antibody produced sustained reductions in triglyceride levels of up to 82 percent, depending on the patient’s genotype, while also lowering the…